Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?

por Karayan-Tapon, L, Wager, M, Guilhot, J, Levillain, P, Marquant, C, Clarhaut, J, Potiron, V, Roche, J
Publicado 2008

Prognostic value of increase in transcript levels of Tp73 ΔEx2-3 isoforms in low-grade glioma patients

por Wager, M, Guilhot, J, Blanc, J-L, Ferrand, S, Milin, S, Bataille, B, Lapierre, F, Denis, S, Chantereau, T, Larsen, C-J, Karayan-Tapon, L
Publicado 2006

Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study

por Wager, M, Menei, P, Guilhot, J, Levillain, P, Michalak, S, Bataille, B, Blanc, J-L, Lapierre, F, Rigoard, P, Milin, S, Duthe, F, Bonneau, D, Larsen, C-J, Karayan-Tapon, L
Publicado 2008

A mesenchymal glioma stem cell profile is related to clinical outcome

por Balbous, A, Cortes, U, Guilloteau, K, Villalva, C, Flamant, S, Gaillard, A, Milin, S, Wager, M, Sorel, N, Guilhot, J, Bennaceur-Griscelli, A, Turhan, A, Chomel, J-C, Karayan-Tapon, L
Publicado 2014